Human VEGF-A Monoclonal Antibody, Endotoxin 0.05 EU/mg
Product Sizes
5 mg
£1617.00
YR0136-5MG
20 mg
£4227.00
YR0136-20MG
About this Product
- SKU:
- YR0136
- Additional Names:
- L-VEGF|MVCD1|VEGF|VPF
- Application:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Clonality:
- Monoclonal
- Extra Details:
- Brolucizumab is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab is a vascular endothelial growth factor (VEGF) inhibitor which targets the major VEGF-A isoforms: VEGF110, VEGF121, and VEGF165. Inhibition of these VEGF-A isoforms reduce proliferation of endothelial cells, vascularization of the tissue, and permeability of the vasculature.
- Formulation:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human VEGF-A
- Isotype:
- IgG1, kappa
- Molecular Weight:
- 150 kDa
- Purity:
- >95%
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ABclonal Technology
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:YR0136
